Skip to main content
. 2020 May 18;12(5):462. doi: 10.3390/pharmaceutics12050462

Figure 1.

Figure 1

The effects of Labrasol® and its related formulations on plasma concentrations of glucose after small intestinal administration of insulin (80 IU/kg) using an in situ closed loop. Glucose concentrations are expressed as a percentage of the initial concentration at time zero. Each value represents the mean ± standard error (S.E.) of three to four rats.